John E. Mullinax
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 38
- CAR-T cell therapy research 19
- Cancer Immunotherapy and Biomarkers 9
- Cancer Cells and Metastasis 7
- Cutaneous Melanoma Detection and Management 4
-
- Sarcoma Diagnosis and Treatment 14
- Co-authors
- Itzhak Avital (9 shared papers)Alexander Stojadinovic (7 shared papers)Ricardo González (13 shared papers)Russell C. Langan (5 shared papers)Jonathan S. Zager (13 shared papers)Udo Rudloff (8 shared papers)Jonathan M. Hernandez (8 shared papers)Sharona Ross (5 shared papers)
- Journals
- Annals of Surgical Oncology (7 papers)Journal of Cancer (5 papers)Cancer Control (4 papers)Journal of Clinical Oncology (4 papers)Journal for ImmunoTherapy of Cancer (4 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
John E. Mullinax
69 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Oncology 573
- Pulmonary and Respiratory Medicine 301
- Hepatology 73
- Immunology 180
- Gastroenterology 40
Countries citing papers authored by John E. Mullinax
This map shows the geographic impact of John E. Mullinax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Mullinax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Mullinax more than expected).
Fields of papers citing papers by John E. Mullinax
This network shows the impact of papers produced by John E. Mullinax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Mullinax. The network helps show where John E. Mullinax may publish in the future.
Co-authors
The 25 scholars most cited alongside John E. Mullinax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 172 | |
| 2 | 2013 | 93 | |
| 3 | 2009 | 88 | |
| 4 | 2018 | 79 | |
| 5 | 2013 | 66 | |
| 6 | 2011 | 63 | |
| 7 | 2012 | 53 | |
| 8 | 2012 | 49 | |
| 9 | 2021 | 37 | |
| 10 | 2018 | 36 | |
| 11 | 2021 | 35 | |
| 12 | 2010 | 33 | |
| 13 | 2008 | 29 | |
| 14 | 2021 | 26 | |
| 15 | 2017 | 25 | |
| 16 | 2016 | 23 | |
| 17 | 2017 | 23 | |
| 18 | 2018 | 21 | |
| 19 | 2010 | 19 | |
| 20 | 2018 | 19 |
About John E. Mullinax
John E. Mullinax is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Genetics, having authored 72 papers that have together received 1.3k indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Sarcoma Diagnosis and Treatment (14 papers), Immunotherapy and Immune Responses (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Cancer Cells and Metastasis (7 papers), Cancer Research and Treatments (6 papers), Virus-based gene therapy research (5 papers) and Cutaneous Melanoma Detection and Management (4 papers). The work is most often cited by research in Oncology (573 citations), Pulmonary and Respiratory Medicine (301 citations), Hepatology (73 citations), Immunology (180 citations) and Gastroenterology (40 citations). John E. Mullinax has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Itzhak Avital, Alexander Stojadinovic, Ricardo González, Russell C. Langan, Jonathan S. Zager, Udo Rudloff, Jonathan M. Hernandez, Sharona Ross, Gordon Wiegand and Desireé Villadolid. Their work appears in journals such as Annals of Surgical Oncology, Journal of Cancer, Cancer Control, Journal of Clinical Oncology and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.